Astemizole/cyclodextrin inclusion complexes: Phase solubility, physicochemical characterization and molecular modeling studies

Journal of Solution Chemistry

Volumn 37, Issue 6, 2008, Pages 875-893

  Al Omari, Mahmoud M ^a   Zughul, Mohammad B ^b   Davies, J Eric D ^c   Badwan, Adnan A ^a  

^a JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

1 H NMR; Astemizole; Cyclodextrin; Hydrophobic effect; Inclusion complexation; Molecular modeling; Phase solubility; Solvation; Thermodynamics

Indexed keywords

EID: 42449157529     PISSN: 00959782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10953-008-9277-z     Document Type: Article

References (39)

1. Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743-1753 (1998)
2. Tinwalla, A.Y., Hoesterey, B.L., Xiang, T.-X., Lim, K., Anderson, B.D.: Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-β-cyclodextrin. Pharm. Res. 10, 1136-1143 (1993)
3. Esclusa-Diaz, M.T., Gayo-Otero, M., Perez-Marcos, M.B., Vila-Jato, J.K., Torres-Labandeira, J.J.: Preparation and evaluation of ketoconazole-β- cyclodestrin multicomponent complexes. Int. J. Pharm. 142, 183-187 (1996)
4. Badwan, A.A., Abu-Malooh, A., Haddadin, M., Ibrahim, H.: Method of solubilizing drugs using cyclodextrins and carboxylic acids. US Patent No. 5646131 A 19970708 (1997)
5. Piel, G., Pirotte, B., Delneuville, I., Neven, P., Llabres, G., Delarge, J., Delattre, L.: Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes. J. Pharm. Sci. 86, 475-480 (1997)
6. Kim, Y., Oksanen, D.A., Massefski, W., Blake, J.F., Duffy, E.M., Chrunyk, B.: Inclusion complexation of ziprasidone mesylate with β-cyclodextrin sulfobutyl ether. J. Pharm. Sci. 87, 1560-1567 (1998)
7. Ping, G., Tabibi, S.E., Yalkowsky, S.H.: Combined effect of complexation and pH on solubilization. J. Pharm. Sci. 87, 1535-1539 (1998)
8. McCandless, R., Yalkowsky, S.H.: Effect of hydroxypropyl-β- cyclodextrin and pH on the solubility of levemopamil HCl. J. Pharm. Sci. 87, 1639-1642 (1998)
9. Piel, G., Evrard, B., Fillet, M., Llabres, G., Delattre, L.: Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrin. Int. J. Pharm. 169, 15-22 (1998)
10. Evard, B., Chiap, P., DeTullio, P., Ghalmi, F., Piel, G., Van Hees, T., Crommen, J., Losson, B., Delattre, L.: Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-β-cyclodextrin. J. Controlled Release. 85, 45-50 (2002)
11. Garcia, J.J., Bolas, F., Torrado, J.J.: Bioavailability and efficacy characteristics of two different oral liquid formulation of albendazole. Int. J. Pharm. 250, 351-358 (2003)
12. Ribeiro, L., Carvalho, R.A., Francisco, D.C., Veiga, F.J.B.: Multicomponent complex formation between vinpocetine, cyclodextrin, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Eur. J. Pharm. Sci. 24, 1-13 (2005)
13. st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. Chatenary Malabry (France): APGI, pp. 579-580 (1995)
14. Ventura, P., Chiesi, P., Pasini, M., Redenti, E., Szejtli, J., Vikmon, M.: Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin. US Patent No. US5855916 (1995)
15. Redenti, E., Szente, L., Szejtli, J.: Drug/cyclodextrin/hydoxy acid multicomponent systems. Properties and pharmaceutical applications. J. Pharm. Sci. 89, 1-8 (2000)
16. Al Omari, M.M., Zughul, M.B., Davies, J.E.D., Badwan, A.A.: Factors contributing to solubility synergism of some basic drugs with β-cyclodextrin in ternary molecular complexes. J. Inclusion Phenom. Macrocycl. Chem. 54, 159-164 (2006)
17. Al-Obaid, A.M., Mian, M.S.: Analytical profile of astemizole. In: Florey, K. (ed.) Analytical Profiles of Drug Substances, vol. 20, pp. 173-208. Academic Press, USA (1991)
18. 1 H-NMR and molecular modeling studies. J. Pharm. Biomed. Anal. 41, 857-865 (2006)
19. Higuchi, T., Connors, K.A.: Phase solubility techniques. Adv. Anal. Chem. Instr. 4, 117-212 (1965)
20. 2 type phase solubility diagrams, complex formation and chemical speciation of soluble species. J. Inclusion Phenom. Macrocycl. Chem. 31, 243-264 (1998)
21. Al Omari, M.M., Zughul, M.B., Davies, J.E.D., Badwan, A.A.: Effect of buffer species on the inclusion complexation of acidic drug celecoxib with cyclodextrin in solution. J. Inclusion Phenom. Macrocycl. Chem. 55, 247-254 (2006)
22. El-Barghouthi, M.I., Masoud, N.A., Al-Kafawein, J.K., Zughul, M.B., Badwan, A.A.: Host-guest interactions of risperidone with natural and modified cyclodextrins: phase solubility, thermodynamics and molecular modeling studies. J. Inclusion Phenom. Macrocycl. Chem. 53, 15-22 (2005)
23. 1 H-NMR and molecular modeling studies. J. Inclusion Phenom. Macrocycl. Chem. 57, 511-517 (2007)
24. Al Omari, M.M., Zughul, M.B., Davies, J.E.D., Badwan, A.A.: Effect of buffer species on the complexation of basic drug terfenadine with β-cyclodextrin. J. Inclusion Phenom. Macrocycl. Chem. 58, 227-235 (2007)
25. Omar, L., El-Barghouthi, M.I., Masoud, N.A., Abdoh, A.A., Al Omari, M.M., Zughul, M.B., Badwan, A.A.: Inclusion complexation of loratadine with natural and modified cyclodextrins: phase solubility and thermodynamic studies. J. Solution Chem. 36, 605-616 (2007)
26. Manrique, Y.J., Pacheco, D.P., Martinez, F.: Thermodynamic of mixing and solvation of ibuprofen and naproxen in propylene glycol and water cosolvent mixtures. J. Solution Chem. 37, 165-181 (2008)
27. Wassvik, C.M., Holmen, A.G., Bergstrom, C.A.S., Zamora, I., Artursson, P.: Contribution of solid-state properties to the aqueous solubility of drugs. Eur. J. Pharm. Sci. 29, 294-305 (2006)
28. Astemizole, USP monograph. In United States Pharmacopoeia (USP), 29th edn., pp. 209-210. USP Convention. INC, Maryland (2006)
29. Taraszewska, J., Migut, K., Kozbiat, M.: Complexation of flutamide by native and modified cyclodextrins. J. Phys. Org. Chem. 16, 121-126 (2003)
30. Bendels, S., Tsinman, O., Wagner, B., Lipp, D., Parrilla, I., Kansy, M., Avdeef, A.: PAMPA-excipient classification gradient maps. Pharm. Res. 23, 2525-2535 (2006)
31. CAS Registry file (accessed June 7, 2007)
32. a of nimesulide. Int. J. Pharm. 176, 261-264 (1999)
33. Chufàn, E.E., Suvire, F.D., Enriz, R.D., Pedregosa, J.C.: A potentiometric and spectrophotometric study on acid-base equilibria in ethanol-aqueous solution of acetazolamide and related compounds. Talanta 49, 859-868 (1999)
34. Nalluri, B.N., Chowdary, K.R., Murthy, K.R., Hayman, A.R., Becket, G.: Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech. 4(1) Article 2 (2003). http://www.aapspharmscitech.org
35. Ribeiro, L., Veiga, F.: Complexation of vinpocetine with cyclodextrins in the presence or absence of polymers, binary and ternary complexes preparation and characterization. J. Inclusion Phenom. Macrocycl. Chem. 44, 251-256 (2002)
36. Connors, K.A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325-1358 (1997)
37. 1 H NMR and ROESY experiments. Eur. J. Pharm. Sci. 18, 285-296 (2003)
38. Aki, H., Niiya, T., Iwase, Y., Kawasaki, Y., Kumai, K., Kimura, T.: Multimodal inclusion complexes of ampicillin with β-cyclodextrin in aqueous solution. Thermochim. Acta 416, 87-92 (2004)
39. Uccello-Barretta, G., Balzano, F., Sicoli, G., Fríglola, C., Aldana, I., Monge, A., Paolino, D., Guccione, S.: Combining NMR and molecular modeling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into β-cyclodextrin. Bioorg. Med. Chem. 12, 447-458 (2004)